METHOD FOR PREVENTING THE COMPLICATIONS OF CHEMOTHERAPY WHILE TREATING ONCOLOGICAL DISEASE

FIELD: medicine, oncology. ^ SUBSTANCE: the second fraction of Dorogov's antiseptic stimulant (DAS-f2) in 5%-novocain solution at 1:5 ratio should be dissolved with water at 1:200. The preparation should be introduced perorally at the dosage of 0.1-0.510-3 mg/kg body weight once daily in the mo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GNEZDILOVA ANNA IVANOVNA, FIALKOVA EVGENIJA ALEKSANDROVNA, GUROV ALEKSANDR EVGENIEVICH
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine, oncology. ^ SUBSTANCE: the second fraction of Dorogov's antiseptic stimulant (DAS-f2) in 5%-novocain solution at 1:5 ratio should be dissolved with water at 1:200. The preparation should be introduced perorally at the dosage of 0.1-0.510-3 mg/kg body weight once daily in the morning about 20-30 min before meals. Moreover, the intake of the preparation suggested should be started from the lowest limit of dosages; range. The prophylaxis should be carried out before, during and after chemotherapy. The innovation in question enables to increase the reserve blood alkalinity, create the conditions for neutralization of acidic products and decrease unfavorable side effects of chemotherapy that leads to cheaper cost of therapy conducted. ^ EFFECT: higher accuracy and efficiency of prophylaxis. ^ 1 cl, 4 ex, 4 tbl